reported that butyrate might exhibit indirect and direct anti-fibrogenic action on fibroblasts by regulating macrophage differentiation and inhibition of histone deacetylase 3, ameliorating skin and lung fibrosis in a mouse model of SSc (Park et al., 2021). The gene discussed is HDAC3; the disease is systemic sclerosis.